SunriseChampion
Senior Member
Not my type.....I'll wash her hair yadda yadda take payment and leave Australia posthaste never to be seen again. Life of a tramp.She clearly earns enough for you to be a kept man!
Not my type.....I'll wash her hair yadda yadda take payment and leave Australia posthaste never to be seen again. Life of a tramp.She clearly earns enough for you to be a kept man!
She clearly earns enough for you to be a kept man!
Now who am I to deny to @SunriseChampion his true calling.............but personally, I think that may be an indication he needs to raise his rate!
I just got laid off from my other job, gotta start my new career at the bottom.
Last week, Pfizer and BioNTech said they were boosting vaccine production to 2 billion doses this year. There's a catch, though: Scaling up a factory in Belgium to help meet that goal means supplies will run short temporarily in Europe, Canada and other places.
BioNTech late last week unveiled a factory upgrade that’ll allow the company and Pfizer to deliver "significantly more doses in the second quarter" but require a short-term disruption of supply. The disruption will affect Europe, Canada and a few other countries, The Wall Street Journal reports. The companies say deliveries will return to normal starting next week.
The manufacturing upgrade will start to boost output in mid-February, BioNTech said, leading to more deliveries in the first quarter and “significantly more in the second quarter.” The companies last week hiked their 2021 output target to 2 billion doses from a prior goal of 1.3 billion doses.
Pushback to the news came swiftly. Six EU countries wrote in a letter to the companies that the situation is "unacceptable," Reuters reports.
“Not only does it impact the planned vaccination schedules, it also decreases the credibility of the vaccination process," the letter reads, according to the news service.
Separately, Germany's government said Pfizer was failing to meet a "binding commitment" on its delivery schedule, the WSJ reports.
Still, the partners are “working relentlessly” on the scale-up, BioNTech said in a statement, “not only expanding their own manufacturing capacities but also by adding further suppliers as well as contract manufacturers to increase total manufacturing capacity.”
The "re-tooling" will increase the production from 1,300,000 to 2,000,000 doses, so I accept the "temporary cut". Hopefully, the "re-tooling" will be short term.Across the Atlantic, deliveries are continuing in the U.S. and are disrupted in Canada, according to various reports. In Ontario, Minister of Health Christine Elliott said “Pfizer is doing some retooling at their plant in Belgium,” so Ontario will “see our supplies reduced for a period of time,” as quoted by the Toronto Sun.
Some municipalities are changing vaccination plans in response, GlobalNews.ca reports. Ontario Premier Doug Ford said the effect of the disruption will be "huge," according to the Sun. He called on Canada's government to pressure Pfizer to increase deliveries.
On the same day BioNTech unveiled the upgrade, the biotech won approval to start manufacturing the vaccine at a German factory it purchased from Novartis in September, Hessenschau reports (German). The Marburg site employs 300 people and is set to produce up to 750 million doses annually, according to the German news outlet.
Stay home unless it's an essential trip. Wear a mask when riding the #TTC.
PS. Did you really think we wouldn't jump on this??
So I watched the city's news conference today and was witness to another float in the pandemic farce parade.
The lot wore their masks when not speaking but took them off when speaking.
Ahem...........yeah
There is zero point in wearing a mask if you're going to take it off when expelling more aerosolised particles than when breathing.
Not sure what the problem is as politicos in central Europe have had no problem speaking whilst masked, seeing as that's the whole point of wearing the bloody things.
It's like pandemic virtue signalling up in this piece.
If they're 2 m from another person, why not?